The effects of dasatinib on muscle regeneration
Proceedings for Annual Meeting of The Japanese Pharmacological Society(2022)
Abstract
As there are no effective treatments for muscular dystrophy (MD), identifying systemically acting small-molecule therapeutics is desirable. Tyrosine phosphorylation of β-dystroglycan, which occurs via tyrosine kinase in dystrophin-deficient muscles, has been reported to induce muscle damage, and several tyrosine kinase inhibitors have been researched as potential therapeutic agents for MD. Nilotinib, a second-generation tyrosine kinase inhibitor, was potentially effective in MD by reducing muscle fibrosis. However, there was a problem that its direct effect on satellite cells inhibited muscle differentiation. Dasatinib, a third-generation tyrosine kinase inhibitor, is also expected to be effective in MD, but its effect on muscle regeneration is unknown.
MoreTranslated text
Key words
muscle regeneration,dasatinib
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined